Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Exenatide modulates visual cortex responses.

Binda P, Eldor R, Huerta C, Adams J, Lancaster J, Fox P, Del Prato S, DeFronzo R, Abdul-Ghani M, Daniele G.

Diabetes Metab Res Rev. 2019 Apr 11:e3167. doi: 10.1002/dmrr.3167. [Epub ahead of print]

PMID:
30974038
2.

The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study.

Martín-Merino E, Llorente-García A, Montero-Corominas D, Huerta C.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):201-208. doi: 10.1002/pds.4674. Epub 2018 Nov 29.

PMID:
30488510
3.

Long-term efficacy of laparoscopic Nissen versus Toupet fundoplication for the management of types III and IV hiatal hernias.

Huerta CT, Plymale M, Barrett P, Davenport DL, Roth JS.

Surg Endosc. 2018 Nov 26. doi: 10.1007/s00464-018-6589-y. [Epub ahead of print]

PMID:
30478698
4.

Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.

Huerta C, Garcia-Casado Z, Bañuls J, Moragon M, Oliver V, Unamuno B, Requena C, Kumar R, Nagore E.

Acta Derm Venereol. 2018 Apr 27;98(5):512-516. doi: 10.2340/00015555-2898.

5.

A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.

Faillie JL, Ferrer P, Gouverneur A, Driot D, Berkemeyer S, Vidal X, Martínez-Zapata MJ, Huerta C, Castells X, Rottenkolber M, Schmiedl S, Sabaté M, Ballarín E, Ibáñez L.

J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6.

PMID:
28487158
6.

Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.

Marvin SA, Russier M, Huerta CT, Russell CJ, Schultz-Cherry S.

J Virol. 2017 Jan 3;91(2). pii: e01417-16. doi: 10.1128/JVI.01417-16. Print 2017 Jan 15.

7.

Diversifying the Pipeline Into Doctoral Nursing Programs: Developing the Doctoral Advancement Readiness Self-Assessment.

DeWitty VP, Tabloski PA, Millett CM, Hambrick ME, Shreffler M, Downing CA, Huerta CG.

J Prof Nurs. 2016 Sep-Oct;32(5S):S68-S75. doi: 10.1016/j.profnurs.2016.03.002. Epub 2016 Mar 19.

PMID:
27659760
8.

New Careers in Nursing: Optimizing Diversity and Student Success for the Future of Nursing.

DeWitty VP, Huerta CG, Downing CA.

J Prof Nurs. 2016 Sep-Oct;32(5S):S4-S13. doi: 10.1016/j.profnurs.2016.03.011. Epub 2016 Apr 1.

PMID:
27659754
9.

Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.

Eldor R, Daniele G, Huerta C, Al-Atrash M, Adams J, DeFronzo R, Duong T, Lancaster J, Zirie M, Jayyousi A, Abdul-Ghani M.

Diabetes Care. 2016 Oct;39(10):1804-10. doi: 10.2337/dc15-2706. Epub 2016 Aug 3.

10.

Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.

Huerta C, Jiang X, Trevino I, Bender CF, Ferguson DA, Probst B, Swinger KK, Stoll VS, Thomas PJ, Dulubova I, Visnick M, Wigley WC.

Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2537-2552. doi: 10.1016/j.bbagen.2016.07.026. Epub 2016 Jul 27.

PMID:
27474998
11.

Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.

Ali MS, Groenwold RH, Belitser SV, Souverein PC, Martín E, Gatto NM, Huerta C, Gardarsdottir H, Roes KC, Hoes AW, de Boer A, Klungel OH.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:114-21. doi: 10.1002/pds.3864.

PMID:
27038357
12.

Case-only designs for studying the association of antidepressants and hip or femur fracture.

de Groot MC, Candore G, Uddin MJ, Souverein PC, Ali MS, Belitser SV, Huerta C, Groenwold RH, Alvarez Y, Slattery J, Korevaar J, Hoes AW, Roes KC, de Boer A, Douglas IJ, Schlienger RG, Reynolds R, Klungel OH, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:103-13. doi: 10.1002/pds.3850.

13.

Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.

Souverein PC, Abbing-Karahagopian V, Martin E, Huerta C, de Abajo F, Leufkens HG, Candore G, Alvarez Y, Slattery J, Miret M, Requena G, Gil MJ, Groenwold RH, Reynolds R, Schlienger RG, Logie JW, de Groot MC, Klungel OH, van Staa TP, Egberts TC, De Bruin ML, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:88-102. doi: 10.1002/pds.3862.

PMID:
27038355
14.

Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe.

Brauer R, Douglas I, Garcia Rodriguez LA, Downey G, Huerta C, de Abajo F, Bate A, Feudjo Tepie M, de Groot MC, Schlienger R, Reynolds R, Smeeth L, Klungel O, Ruigómez A.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:29-38. doi: 10.1002/pds.3861.

PMID:
27038354
15.

Type I Interferon Response Limits Astrovirus Replication and Protects against Increased Barrier Permeability In Vitro and In Vivo.

Marvin SA, Huerta CT, Sharp B, Freiden P, Cline TD, Schultz-Cherry S.

J Virol. 2015 Dec 9;90(4):1988-96. doi: 10.1128/JVI.02367-15. Print 2016 Feb 15.

16.

Nimesulide-loaded nanoparticles for the potential coadjuvant treatment of prostate cancer.

Huerta C, Aberturas Mdel R, Molpeceres J.

Int J Pharm. 2015 Sep 30;493(1-2):152-60. doi: 10.1016/j.ijpharm.2015.07.027. Epub 2015 Jul 20.

PMID:
26205513
17.

Prevalence of antibiotic use: a comparison across various European health care data sources.

Brauer R, Ruigómez A, Downey G, Bate A, Garcia Rodriguez LA, Huerta C, Gil M, de Abajo F, Requena G, Alvarez Y, Slattery J, de Groot M, Souverein P, Hesse U, Rottenkolber M, Schmiedl S, de Vries F, Tepie MF, Schlienger R, Smeeth L, Douglas I, Reynolds R, Klungel O.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:11-20. doi: 10.1002/pds.3831. Epub 2015 Jul 7.

18.

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.

Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, Miret M, Schneider C, Gil M, Souverein PC, De Bruin ML, Slattery J, De Groot MC, Hesse U, Rottenkolber M, Schmiedl S, Montero D, Bate A, Ruigomez A, García-Rodríguez LA, Johansson S, de Vries F, Schlienger RG, Reynolds RF, Klungel OH, de Abajo FJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:56-65. doi: 10.1002/pds.3825. Epub 2015 Jul 7.

PMID:
26149383
19.

Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines.

Requena G, Logie J, Martin E, Boudiaf N, González González R, Huerta C, Alvarez A, Webb D, Bate A, García Rodríguez LA, Reynolds R, Schlienger R, Gardarsdottir H, de Groot M, Klungel OH, de Abajo F, Douglas IJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:79-87. doi: 10.1002/pds.3822. Epub 2015 Jun 26.

20.

Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project.

Requena G, Huerta C, Gardarsdottir H, Logie J, González-González R, Abbing-Karahagopian V, Miret M, Schneider C, Souverein PC, Webb D, Afonso A, Boudiaf N, Martin E, Oliva B, Alvarez A, De Groot MC, Bate A, Johansson S, Schlienger R, Reynolds R, Klungel OH, de Abajo FJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:66-78. doi: 10.1002/pds.3816. Epub 2015 Jun 23.

PMID:
26100105
21.

Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.

Rottenkolber M, Voogd E, van Dijk L, Primatesta P, Becker C, de Groot MC, Plana E, Alvarez Y, Durand J, Slattery J, Afonso A, Requena G, Huerta C, Alvarez A, de Abajo F, Tauscher M, Hasford J, Fischer R, Reynolds R, Schmiedl S.

Respir Med. 2015 Jul;109(7):828-37. doi: 10.1016/j.rmed.2015.01.010. Epub 2015 Jan 31.

22.

Ascertainment of acute liver injury in two European primary care databases.

Ruigómez A, Brauer R, Rodríguez LA, Huerta C, Requena G, Gil M, de Abajo F, Downey G, Bate A, Tepie MF, de Groot M, Schlienger R, Reynolds R, Klungel O.

Eur J Clin Pharmacol. 2014 Oct;70(10):1227-35. doi: 10.1007/s00228-014-1721-y. Epub 2014 Jul 29.

PMID:
25066450
23.

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications.

Abbing-Karahagopian V, Huerta C, Souverein PC, de Abajo F, Leufkens HG, Slattery J, Alvarez Y, Miret M, Gil M, Oliva B, Hesse U, Requena G, de Vries F, Rottenkolber M, Schmiedl S, Reynolds R, Schlienger RG, de Groot MC, Klungel OH, van Staa TP, van Dijk L, Egberts AC, Gardarsdottir H, De Bruin ML.

Eur J Clin Pharmacol. 2014 Jul;70(7):849-57. doi: 10.1007/s00228-014-1676-z. Epub 2014 May 3.

PMID:
24793010
24.

Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases.

Requena G, Abbing-Karahagopian V, Huerta C, De Bruin ML, Alvarez Y, Miret M, Hesse U, Gardarsdottir H, Souverein PC, Slattery J, Schneider C, Rottenkolber M, Schmiedl S, Gil M, De Groot MC, Bate A, Ruigómez A, García Rodríguez LA, Johansson S, de Vries F, Montero D, Schlienger R, Reynolds R, Klungel OH, de Abajo FJ.

Calcif Tissue Int. 2014 Jun;94(6):580-9. doi: 10.1007/s00223-014-9850-y. Epub 2014 Apr 1.

PMID:
24687523
25.

Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparison.

de Groot MC, Schuerch M, de Vries F, Hesse U, Oliva B, Gil M, Huerta C, Requena G, de Abajo F, Afonso AS, Souverein PC, Alvarez Y, Slattery J, Rottenkolber M, Schmiedl S, Van Dijk L, Schlienger RG, Reynolds R, Klungel OH.

Epilepsia. 2014 May;55(5):666-73. doi: 10.1111/epi.12557. Epub 2014 Feb 27.

26.

Neural bases of food perception: coordinate-based meta-analyses of neuroimaging studies in multiple modalities.

Huerta CI, Sarkar PR, Duong TQ, Laird AR, Fox PT.

Obesity (Silver Spring). 2014 Jun;22(6):1439-46. doi: 10.1002/oby.20659.

27.

The "super mutant" of yeast FMN adenylyltransferase enhances the enzyme turnover rate by attenuating product inhibition.

Huerta C, Grishin NV, Zhang H.

Biochemistry. 2013 May 28;52(21):3615-7. doi: 10.1021/bi400454w. Epub 2013 May 15.

28.

Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study.

Erviti J, Alonso A, Oliva B, Gorricho J, López A, Timoner J, Huerta C, Gil M, De Abajo F.

BMJ Open. 2013 Jan 30;3(1). pii: e002091. doi: 10.1136/bmjopen-2012-002091.

29.

Identification of a candidate therapeutic autophagy-inducing peptide.

Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, Wilkins AD, Sun Q, Pallauf K, MacDuff D, Huerta C, Virgin HW, Helms JB, Eerland R, Tooze SA, Xavier R, Lenschow DJ, Yamamoto A, King D, Lichtarge O, Grishin NV, Spector SA, Kaloyanova DV, Levine B.

Nature. 2013 Feb 14;494(7436):201-6. doi: 10.1038/nature11866. Epub 2013 Jan 30.

30.

Expression of hsp70, hsp100 and ubiquitin in Aloe barbadensis Miller under direct heat stress and under temperature acclimation conditions.

Huerta C, Freire M, Cardemil L.

Plant Cell Rep. 2013 Feb;32(2):293-307. doi: 10.1007/s00299-012-1363-4. Epub 2012 Oct 31.

PMID:
23111788
31.

Using step cadence goals to increase moderate-to-vigorous-intensity physical activity.

Marshall SJ, Nicaise V, Ji M, Huerta C, Haubenstricker J, Levy SS, Ainsworth B, Elder JE.

Med Sci Sports Exerc. 2013 Mar;45(3):592-602. doi: 10.1249/MSS.0b013e318277a586.

PMID:
23059868
32.

SU-E-I-72: Modulation of Hypothalamic Connectivity by Food Ingestion.

Huerta C, Li J, Wey H, Duong T.

Med Phys. 2012 Jun;39(6Part5):3641. doi: 10.1118/1.4734789.

PMID:
28517643
33.

Structure of C3PO and mechanism of human RISC activation.

Ye X, Huang N, Liu Y, Paroo Z, Huerta C, Li P, Chen S, Liu Q, Zhang H.

Nat Struct Mol Biol. 2011 Jun;18(6):650-7. doi: 10.1038/nsmb.2032. Epub 2011 May 8.

34.

Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study.

Huerta C, Rivero E, Montoro MA, García-Rodriguez LA.

Aliment Pharmacol Ther. 2011 Apr;33(8):969-78. doi: 10.1111/j.1365-2036.2011.04614.x. Epub 2011 Mar 1.

35.

Use of food and space by tunneler dung beetles (Coleoptera; Scarabaeinae) during reproduction.

Huerta C, Anduaga S, López-Portillo J, Halffter G.

Environ Entomol. 2010 Aug;39(4):1165-9. doi: 10.1603/EN09321.

PMID:
22127167
36.
37.

Structure and mechanism of a eukaryotic FMN adenylyltransferase.

Huerta C, Borek D, Machius M, Grishin NV, Zhang H.

J Mol Biol. 2009 Jun 5;389(2):388-400. doi: 10.1016/j.jmb.2009.04.022. Epub 2009 Apr 16.

38.

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP.

Neurogenetics. 2009 Oct;10(4):347-53. doi: 10.1007/s10048-009-0187-z. Epub 2009 Mar 24.

39.

Intracellular MUC1 peptides inhibit cancer progression.

Bitler BG, Menzl I, Huerta CL, Sands B, Knowlton W, Chang A, Schroeder JA.

Clin Cancer Res. 2009 Jan 1;15(1):100-9. doi: 10.1158/1078-0432.CCR-08-1745.

40.

Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism.

Huerta C, Johansson S, Wallander MA, Rodríguez LA.

Thromb J. 2008 Aug 18;6:10. doi: 10.1186/1477-9560-6-10.

41.

Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.

Alvarez V, Corao AI, Sánchez-Ferrero E, De Mena L, Alonso-Montes C, Huerta C, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, García-Castro M, Coto E.

Neurosci Lett. 2008 Feb 13;432(1):79-82. doi: 10.1016/j.neulet.2007.12.010. Epub 2007 Dec 15.

PMID:
18248889
42.

Structural basis for substrate binding and the catalytic mechanism of type III pantothenate kinase.

Yang K, Strauss E, Huerta C, Zhang H.

Biochemistry. 2008 Feb 5;47(5):1369-80. doi: 10.1021/bi7018578. Epub 2008 Jan 11.

PMID:
18186650
43.

Incidence and risk factors for psoriasis in the general population.

Huerta C, Rivero E, Rodríguez LA.

Arch Dermatol. 2007 Dec;143(12):1559-65.

PMID:
18087008
45.

Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.

Huerta C, Johansson S, Wallander MA, García Rodríguez LA.

Arch Intern Med. 2007 May 14;167(9):935-43.

PMID:
17502535
46.

No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes.

Huerta C, Sánchez-Ferrero E, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Alvarez V.

Neurosci Lett. 2007 Feb 21;413(3):202-5. Epub 2006 Dec 15.

PMID:
17174475
47.

Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.

Dächsel JC, Mata IF, Ross OA, Taylor JP, Lincoln SJ, Hinkle KM, Huerta C, Ribacoba R, Blazquez M, Alvarez V, Farrer MJ.

Neurosci Lett. 2006 Dec 20;410(2):80-4.

PMID:
17095157
48.

Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population.

Huerta C, Varas-Lorenzo C, Castellsague J, García Rodríguez LA.

Heart. 2006 Nov;92(11):1610-5. Epub 2006 May 22.

49.

LRRK2 mutations are a common cause of Parkinson's disease in Spain.

Mata IF, Ross OA, Kachergus J, Huerta C, Ribacoba R, Moris G, Blazquez M, Guisasola LM, Salvador C, Martinez C, Farrer M, Alvarez V.

Eur J Neurol. 2006 Apr;13(4):391-4.

PMID:
16643318
50.

Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy.

Castro MG, Huerta C, Reguero JR, Soto MI, Doménech E, Alvarez V, Gómez-Zaera M, Nunes V, González P, Corao A, Coto E.

Int J Cardiol. 2006 Sep 20;112(2):202-6. Epub 2005 Nov 28.

PMID:
16313983

Supplemental Content

Loading ...
Support Center